Silo Pharma, Inc. (NASDAQ:SILO) Short Interest Update

Silo Pharma, Inc. (NASDAQ:SILO) saw a significant growth in short interest in the month of July. As of July 15th, there was short interest totalling 88,000 shares, a growth of 30.6% from the June 30th total of 67,400 shares. Based on an average daily trading volume, of 4,980,000 shares, the days-to-cover ratio is presently 0.0 days. Currently, 2.5% of the shares of the company are short sold.

Silo Pharma Price Performance

NASDAQ:SILO traded up $0.15 during trading hours on Monday, hitting $2.47. 853,307 shares of the stock traded hands, compared to its average volume of 2,333,644. Silo Pharma has a 1 year low of $0.84 and a 1 year high of $4.50. The stock has a 50 day moving average price of $1.53 and a 200 day moving average price of $1.65.

Silo Pharma (NASDAQ:SILO) last issued its quarterly earnings results on Monday, May 13th. The company reported ($0.28) earnings per share for the quarter. Silo Pharma had a negative net margin of 4,992.30% and a negative return on equity of 51.75%. The firm had revenue of $0.02 million for the quarter.

Silo Pharma Company Profile

Silo Pharma. Inc, a developmental stage biopharmaceutical company, develops traditional therapeutics and psychedelic medicine. Its lead program includes SPC-15, an intranasal drug targeting post-traumatic stress disorder (PTSD) and stress-induced anxiety disorders; and SP-26, a ketamine-based loaded implant indicated for fibromyalgia and chronic pain relief.